STOCK TITAN
  1. Home
  2. Sec-filings
  3. STIM
  4. [Form 4] Neuronetics, Inc. Insider Trading Activity

Neuronetics (STIM) director awarded 30,000 RSUs vesting by 2027

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cucuz Sasha reported acquisition or exercise transactions in this Form 4 filing.

Neuronetics, Inc. director Sasha Cucuz received an award of 30,000 restricted stock units (RSUs) of common stock. The RSUs vest on the earlier of May 28, 2027 or a Board-approved separation of service or change in control, in each case requiring continuous service until that date.

Each RSU represents a contingent right to receive one share of Neuronetics common stock. Following this grant, Cucuz directly holds 1,542,798 shares. Separate indirectly held shares are reported as held by Greybrook Health Inc. (516,084 shares) and Greybrook Realty Partners Inc. (2,042 shares), with beneficial ownership of these indirect holdings disclaimed except to the extent of his pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Cucuz Sasha
Role null
Type Security Shares Price Value
Grant/Award Common Stock 30,000 $0.00 --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 1,542,798 shares (Direct, null); Common Stock — 2,042 shares (Indirect, By Greybrook Realty Partners Inc.)
Footnotes (1)
  1. Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
RSU grant size 30,000 RSUs Award to director Sasha Cucuz on May 28, 2026
RSU vesting date May 28, 2027 Vests earlier of this date or certain board-approved events
Direct holdings after grant 1,542,798 shares Neuronetics common stock held directly by Sasha Cucuz
Indirect holdings via Greybrook Health Inc. 516,084 shares Neuronetics common stock held by Greybrook Health Inc.
Indirect holdings via Greybrook Realty Partners Inc. 2,042 shares Neuronetics common stock held by Greybrook Realty Partners Inc.
RSU price per share $0.0000 per share Grant price for 30,000 RSUs (compensation award)
restricted stock unit ("RSU") financial
"Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027..."
change in control financial
"...or change in control of the Issuer, in each case subject to continuous service..."
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein..."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"...except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report..."
Section 16 regulatory
"...shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cucuz Sasha
(Last)(First)(Middle)
C/O NEURONETICS, INC.
3222 PHOENIXVILLE PIKE
(Street)
MALVERN PENNSYLVANIA 19355
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/28/2026A30,000(1)A$0(2)1,542,798D
Common Stock2,042(3)IBy Greybrook Realty Partners Inc.
Common Stock516,084(3)IBy Greybrook Health Inc.
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date.
2. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
3. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
/s/ Francis Brown, as Attorney-in-Fact05/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Neuronetics (STIM) director Sasha Cucuz receive in this Form 4?

Sasha Cucuz received a grant of 30,000 restricted stock units (RSUs) of Neuronetics common stock. This is a compensation-related award, not an open-market purchase or sale, and each RSU will convert into one share when it vests.

When do Sasha Cucuz’s 30,000 Neuronetics (STIM) RSUs vest?

The 30,000 RSUs vest on the earlier of May 28, 2027 or a Board-approved separation of service or change in control. In each case, vesting requires continuous service by Cucuz through the applicable vesting date.

How many Neuronetics (STIM) shares does Sasha Cucuz hold after this RSU grant?

After the grant, Sasha Cucuz is reported as directly holding 1,542,798 Neuronetics common shares. Additional shares are reported as indirectly held through Greybrook Health Inc. and Greybrook Realty Partners Inc., with beneficial ownership of those indirect holdings disclaimed except for his pecuniary interest.

What does each Neuronetics (STIM) RSU granted to Sasha Cucuz represent?

Each restricted stock unit represents a contingent right to receive one share of Neuronetics common stock. The shares will be delivered if and when the RSUs vest under the stated conditions tied to service and potential corporate events.

How are the indirect Neuronetics (STIM) holdings attributed in this Form 4?

The filing shows 516,084 shares held by Greybrook Health Inc. and 2,042 shares held by Greybrook Realty Partners Inc. Sasha Cucuz disclaims beneficial ownership of these indirect holdings except to the extent of his pecuniary interest in those entities.